332 results on '"Carrion, Ricardo"'
Search Results
2. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
3. Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioning
4. Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control.
5. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study.
6. Fetal brain vulnerability to SARS-CoV-2 infection
7. Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis
8. O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY
9. Auditory N100 Amplitude Deficits Predict Conversion to Psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) Cohort
10. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
11. SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
12. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort
13. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
14. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
15. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies
16. Visual cortical plasticity and the risk for psychosis: An interim analysis of the North American Prodrome Longitudinal Study
17. Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome
18. 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis
19. M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis
20. 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth
21. 42. Heterogeneity of Neuropsychological Profiles in the Prodrome to Psychosis: An Examination of the Association Between Cognition and Clinical Outcomes in NAPLS-1
22. Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium
23. Reliability of mismatch negativity event-related potentials in a multisite, traveling subjects study
24. Patterns and perceptions of face-to-face and digital communication in the clinical high risk and early stages of psychosis
25. Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge
26. Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
27. Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis
28. Protease inhibitors targeting coronavirus and filovirus entry
29. Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation
30. Author Correction: Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
31. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline
32. Experimental cross-species infection of common marmosets by titi monkey adenovirus.
33. Prediction of functional outcome in young patients with a recent-onset psychiatric disorder: Beyond the traditional diagnostic classification system
34. Authors' reply to comments on: Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns
35. Theory of Mind as a mediator variable between neurocognition and functioning in young individuals in treatment with secondary services for non-psychotic disorders
36. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome
37. Recreational cannabis use over time in individuals at clinical high risk for psychosis: Lack of associations with symptom, neurocognitive, functioning, and treatment patterns
38. Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge
39. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
40. Characterization of Immune Responses Induced by Ebola Virus Glycoprotein (GP) and Truncated GP Isoform DNA Vaccines and Protection Against Lethal Ebola Virus Challenge in Mice
41. Genetic Changes at the Glycoprotein Editing Site Associated With Serial Passage of Sudan Virus
42. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis
43. Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs
44. Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development
45. Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates
46. Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development
47. P517. Aggression and Social Cognition in Schizophrenia Spectrum Disorders
48. A Truth that's Told with Bad Intent: An ERP Study of Deception
49. Rapid detection and quantification of Ebola Zaire virus by one-step real-time quantitative reverse transcription-polymerase chain reaction
50. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.